{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:42:30Z","timestamp":1761388950891,"version":"build-2065373602"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2007,8,1]],"date-time":"2007-08-01T00:00:00Z","timestamp":1185926400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Neurophysiology"],"published-print":{"date-parts":[[2007,8]]},"DOI":"10.1016\/j.clinph.2007.05.065","type":"journal-article","created":{"date-parts":[[2007,6,28]],"date-time":"2007-06-28T09:03:26Z","timestamp":1183021406000},"page":"1835-1841","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Atomoxetine treatment of ADHD in Tourette Syndrome: Reduction in motor cortex inhibition correlates with clinical improvement"],"prefix":"10.1016","volume":"118","author":[{"given":"Donald L.","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tara D.","family":"Lipps","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Natarajan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jared","family":"Brandyberry","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhewu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F. Randy","family":"Sallee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eric M.","family":"Wassermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.clinph.2007.05.065_bib1","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1212\/01.wnl.0000188869.58300.a7","article-title":"Atomoxetine treatment in children and adolescents with ADHD and comorbid tic disorders","volume":"65","author":"Allen","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.clinph.2007.05.065_bib2","unstructured":"American Psychiatric Association. DSM-IV-TR. Washington, DC: American Psychiatric Association; 2000."},{"issue":"1\u20132","key":"10.1016\/j.clinph.2007.05.065_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.neulet.2006.06.026","article-title":"Modulation of transcallosally mediated motor inhibition in children with attention deficit hyperactivity disorder (ADHD) by medication with methylphenidate (MPH)","volume":"405","author":"Buchmann","year":"2006","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.clinph.2007.05.065_bib4","first-page":"17","article-title":"Attention deficit hyperactivity disorder: the childhood co-morbidity that most influences the disability burden in Tourette syndrome","volume":"99","author":"Denckla","year":"2006","journal-title":"Adv Neurol"},{"year":"1998","series-title":"ADHD Rating Scale-IV: checklist, norms, and clinical interpretations","author":"DuPaul","key":"10.1016\/j.clinph.2007.05.065_bib5"},{"issue":"12","key":"10.1016\/j.clinph.2007.05.065_bib6","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/088307380101601205","article-title":"Subjective reactions of children to single-pulse transcranial magnetic stimulation","volume":"16","author":"Garvey","year":"2001","journal-title":"J Child Neurol"},{"issue":"6","key":"10.1016\/j.clinph.2007.05.065_bib7","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1345\/aph.1G582","article-title":"Atomoxetine versus stimulants for treatment of attention deficit\/hyperactivity disorder","volume":"40","author":"Gibson","year":"2006","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.clinph.2007.05.065_bib8","first-page":"107","article-title":"Motor cortex inhibitory function in Tourette Syndrome, attention deficit disorder, and obsessive compulsive disorder \u2013 studies using transcranial magnetic stimulation","volume":"99","author":"Gilbert","year":"2006","journal-title":"Adv Neurol"},{"key":"10.1016\/j.clinph.2007.05.065_bib9","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1002\/mds.20044","article-title":"Association of cortical disinhibition with tic, ADHD, and OCD severity in Tourette Syndrome","volume":"19","author":"Gilbert","year":"2004","journal-title":"Mov Disord"},{"issue":"8","key":"10.1016\/j.clinph.2007.05.065_bib10","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1016\/j.clinph.2003.10.037","article-title":"Should transcranial magnetic stimulation research in children be considered minimal risk?","volume":"115","author":"Gilbert","year":"2004","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.clinph.2007.05.065_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/sj.npp.1300806","article-title":"Comparison of the inhibitory and excitatory effects of ADHD medications methylphenidate and atomoxetine on motor cortex","volume":"31","author":"Gilbert","year":"2006","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.clinph.2007.05.065_bib12","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/j.biopsych.2005.02.022","article-title":"TMS-evoked cortical inhibition: a consistent marker of ADHD scores in Tourette Syndrome","volume":"57","author":"Gilbert","year":"2005","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.clinph.2007.05.065_bib13","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1093\/brain\/awl147","article-title":"Dopamine transporter genotype influences the physiological response to medication in ADHD","volume":"129","author":"Gilbert","year":"2006","journal-title":"Brain"},{"issue":"2","key":"10.1016\/j.clinph.2007.05.065_bib14","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00213-002-1206-z","article-title":"Intracortical excitability is modulated by a norepinephrine-reuptake inhibitor as measured with paired-pulse transcranial magnetic stimulation","volume":"164","author":"Herwig","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.clinph.2007.05.065_bib15","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/00001756-200304150-00023","article-title":"Methylphenidate facilitates and disinhibits the motor cortex in intact humans","volume":"14","author":"Ilic","year":"2003","journal-title":"Neuroreport"},{"issue":"2","key":"10.1016\/j.clinph.2007.05.065_bib16","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1055\/s-2003-39049","article-title":"Methylphenidate enhances both intracortical inhibition and facilitation in healthy adults","volume":"36","author":"Kirschner","year":"2003","journal-title":"Pharmacopsychiatry"},{"issue":"4","key":"10.1016\/j.clinph.2007.05.065_bib17","first-page":"995","article-title":"The children\u2019s depression, inventory (CDI)","volume":"21","author":"Kovacs","year":"1985","journal-title":"Psychopharmacol Bull"},{"issue":"7","key":"10.1016\/j.clinph.2007.05.065_bib18","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1097\/00004583-200207000-00008","article-title":"Atomoxetine and methylphenidate treatment in children with ADHD: a prospective, randomized, open-label trial","volume":"41","author":"Kratochvil","year":"2002","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/j.clinph.2007.05.065_bib19","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1113\/jphysiol.1993.sp019912","article-title":"Corticocortical inhibition in human motor cortex","volume":"471","author":"Kujirai","year":"1993","journal-title":"J Physiol"},{"issue":"4","key":"10.1016\/j.clinph.2007.05.065_bib20","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1097\/00004583-198907000-00015","article-title":"The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity","volume":"28","author":"Leckman","year":"1989","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"issue":"11","key":"10.1016\/j.clinph.2007.05.065_bib21","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1176\/appi.ajp.159.11.1896","article-title":"Once-daily atomoxetine treatment for children and adolescents with attention deficit hyperactivity disorder: a randomized, placebo-controlled study","volume":"159","author":"Michelson","year":"2002","journal-title":"Am J Psychiatry"},{"issue":"1","key":"10.1016\/j.clinph.2007.05.065_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1034\/j.1600-0447.2003.02114.x","article-title":"Methylphenidate and intracortical excitability: opposite effects in healthy subjects and attention-deficit hyperactivity disorder","volume":"107","author":"Moll","year":"2003","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/j.clinph.2007.05.065_bib23","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1002\/ana.77","article-title":"Children with comorbid attention-deficit-hyperactivity disorder and tic disorder: evidence for additive inhibitory deficits within the motor system","volume":"49","author":"Moll","year":"2001","journal-title":"Ann Neurol"},{"issue":"1\u20132","key":"10.1016\/j.clinph.2007.05.065_bib24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0304-3940(00)00980-0","article-title":"Deficient intracortical inhibition in drug-naive children with attention-deficit hyperactivity disorder is enhanced by methylphenidate","volume":"284","author":"Moll","year":"2000","journal-title":"Neurosci Lett"},{"issue":"3","key":"10.1016\/j.clinph.2007.05.065_bib25","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0304-3940(02)00803-0","article-title":"Enhancement of human cortico-motoneuronal excitability by the selective norepinephrine reuptake inhibitor reboxetine","volume":"330","author":"Plewnia","year":"2002","journal-title":"Neurosci Lett"},{"issue":"1","key":"10.1016\/j.clinph.2007.05.065_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1089\/104454603321666199","article-title":"Atomoxetine pharmacokinetics in children and adolescents with attention deficit hyperactivity disorder","volume":"13","author":"Witcher","year":"2003","journal-title":"J Child Adolest Psychopharmacol"},{"issue":"8","key":"10.1016\/j.clinph.2007.05.065_bib27","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/j.clinph.2004.03.006","article-title":"TMS and drugs","volume":"115","author":"Ziemann","year":"2004","journal-title":"Clin Neurophysiol"},{"issue":"6","key":"10.1016\/j.clinph.2007.05.065_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0924-980X(97)00050-7","article-title":"Changes in human motor cortex excitability induced by dopaminergic and anti-dopaminergic drugs","volume":"105","author":"Ziemann","year":"1997","journal-title":"Electroencephalogr Clin Neurophysiol"}],"container-title":["Clinical Neurophysiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245707002787?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1388245707002787?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T10:39:06Z","timestamp":1761388746000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1388245707002787"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8]]}},"alternative-id":["S1388245707002787"],"URL":"https:\/\/doi.org\/10.1016\/j.clinph.2007.05.065","relation":{},"ISSN":["1388-2457"],"issn-type":[{"type":"print","value":"1388-2457"}],"subject":[],"published":{"date-parts":[[2007,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Atomoxetine treatment of ADHD in Tourette Syndrome: Reduction in motor cortex inhibition correlates with clinical improvement","name":"articletitle","label":"Article Title"},{"value":"Clinical Neurophysiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinph.2007.05.065","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2007 International Federation of Clinical Neurophysiology. Published by Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}